Altered T‐cell subpopulations in recurrent pregnancy loss patients with cellular immune abnormalities
Samaneh Abdolmohammadi‐Vahid(Tabriz University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Bahman Yousefi(Semnan University of Medical Sciences), Reza Rikhtegar(Tabriz University of Medical Sciences), Leili Aghebati‐Maleki(Tabriz University of Medical Sciences), Mahnaz Ghaebi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Majid Ahmadi(Tabriz University of Medical Sciences), Mohammad Nouri(Tabriz University of Medical Sciences), Reza Mousavi Ardehaie(Mashhad University of Medical Sciences), Shahla Danaei(Academic Center for Education, Culture and Research), Parvin Hakimi(Tabriz University of Medical Sciences)
Cited by 63
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
|Journal of Cellular Physiology|2017|150